Skip to main content

Table 2 EC50 values in the LHRH receptor expressing HCC1806 and MDA-MB-231 cells and in LHRH-receptor negative LTK (-) cells subsequent to coincubation with AEZS-125 with and without pretreatment with 100 μM triptorelin

From: Triple negative breast cancers express receptors for LHRH and are potential therapeutic targets for cytotoxic LHRH-analogs, AEZS 108 and AEZS 125

10-minute pretreatment

10-minute treatment

EC50 of AEZS-125 (nM)

  

LTK (-)

HCC1806

MDA-MB-231

1% DMSO solvent control

AEZS-125

1070.0 ± 351.1

238.1 ± 194.6

392.0 ± 136.6

(n = 3)

(n = 3)

(n = 4)

100 μM Triptorelin

AEZS-125

613.8 ± 217.4

282.7 ± 151.2

499.0 ± 140.1

(n = 3)

(n = 3)

(n = 4)